Add BrightSurf on Google Email

Oncotarget | Kinase activity in renal cell carcinoma, benign renal tissue and in response to tyrosine kinase inhibitors

Researchers identified differences in PTK activity between normal and cancer kidney tissue, with Src family kinases and PI3K pathways exhibiting high activity. Ex vivo treatment of clear cell RCC with TKIs revealed that tivozanib and cabozantinib were more potent inhibitors than sunitinib or pazopanib.

SourceImpact Journals LLC·JournalOncotarget·TypeData/statistical analysis·DateAug 17, 2022

Invasion of the brain tumors

Researchers discovered the p75NTR receptor plays a key role in glioma invasion, with expression sufficient to induce aggressive tumor growth. This finding highlights a previously unknown function of the receptor and suggests it may be a novel therapeutic target.

SourcePLOS·JournalPLOS Biology·DateAug 13, 2007